OTC Watch

All stocks / NYMXF

NYMOX PHARMACEUTICAL CORP NYMXF

Nymox Pharmaceutical (NYMXF): no warning signs from our rules in the last 12 months. Each fact links to its SEC filing.

Estimated float OTCIDCanada
Live quote on OTC Markets

Market listing

Full name
NYMOX PHARMACEUTICALS CORP(BAHAMAS)
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Website
nymox.com
Source: Stockwatch, 2026-11-17

News headlines

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
2026-06-17 10:45 · News Release
NYMOX Provides Current Update
2026-06-02 16:00 · News Release
NYMOX Provides Recent Updates
2026-03-27 16:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

Signals

Estimated float2025-12-31

Estimated float about 102,040,140 shares as of 2025-12-31: 102,040,140 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2018-12-31
64.7M
2019-12-31
71.2M
2020-12-31
78.0M
2021-12-31
85.5M
2022-12-31
90.5M
2023-12-31
93.5M
2024-12-31
94.5M
2025-12-31
102.0M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-09-29 20-F/AFORM 20-F/A
2026-09-16 20-F/AFORM 20-F/A
2026-09-14 20-FFORM 20-F
2026-08-31 6-KFORM 6-K
2026-08-07 6-KFORM 6-K
2026-06-03 6-KFORM 6-K
2026-03-27 6-KFORM 6-K

Common questions about NYMXF

Does NYMXF file reports with the SEC?

Yes. Nymox Pharmaceutical files with the SEC under company number 0001018735. The most recent filing we hold is a 20-F/A dated 2026-09-29.

Source record

How many NYMXF shares are outstanding?

102,040,140 shares as of 2025-12-31, as reported to the SEC.

Source record

Has NYMXF filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.